UK HealthTech Ready To Take The Digital Challenge With Focused Actions

Digital tools and maximizing the data derived from them will influence the delivery of health care in ways and to extents yet unknown. Andrew Davies, market access director for UK industry group ABHI, explains the industry's planning around this, and calls for a rethink on innovation market access structures, which are still failing to meet industry's needs.

SC1805_Digital Partners_465653942_1200.jpg

Not every story on UK heath care planning needs to start with Brexit, although the Brexit white paper-induced cabinet reshuffle this week well might just play out well for those urging faster integration of digital concepts in the NHS.Matt Hancock, former minister of state for digital and culture, has been elevated to health and social care secretary to fill the post vacated by Jeremy Hunt. (Also see "Latest UK Political Shenanigans: What Medtech Needs To Know" - Medtech Insight, 10 July, 2018.) Could this 40-year-old's hands-on approach to digital policy (Hancock was reputedly the first MP to have his own smartphone app – although not without issues) turn into an unexpected "Brexit dividend" for the UK health-care provider?

The UK healthtech industry would applaud that notion. Digital will have a significant impact on how health services are delivered,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

More from Medtech Insight

Ceryx Medical Amasses £11M To Develop Adaptive Cardiac Pacing Technology

 

The Development Bank of Wales and London-based Parkwalk Advisors led an investment round of £5m, almost doubling Ceryx Medical's total investment to date.

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By 

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

Innovative Wants Injunction Against J&J Subsidiary After $442M Antitrust Verdict

 
• By 

Innovative Healthcare is asking for a permanent injunction against Johnson & Johnson subsidiary Biosense Webster after winning a $442 million antitrust verdict. The injunction aims to prevent continued anticompetitive practices in the electrophysiology catheter market.